Search filters

List of works by Johannes H Schulte

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro

scientific article published on 12 June 2017

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature

scientific article

Author Correction: The landscape of genomic alterations across childhood cancers

scientific article published in Nature

CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells ⬇️

scientific article published on 08 March 2011

Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre ⬇️

scientific article published on July 17, 2013

Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma

scientific article

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma

scientific article published on 16 November 2020

IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.

scientific article published on 09 March 2015

Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development

scientific article published on December 2015

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years ⬇️

scientific article published on July 24, 2013

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

scientific article published on 27 August 2016

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

scientific article published on 18 August 2010

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

scientific article published on 10 June 2022

Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance

scientific article published on 04 November 2021

Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer

scientific article published in 2024

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

scientific article published on 29 June 2015

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

scientific article published on 23 November 2021

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.

scientific article

The landscape of genomic alterations across childhood cancers

scientific article published on 28 February 2018

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

scientific article

WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma

miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin

scientific article

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

scientific article

Paulina is supported by:

About Paulina

Help